One small-cap AI biotech just put a set of numbers behind its version of that story, and they show a company whose pivot is starting to appear in its financials rather than only in its slide decks.
The migration to quantum-resistant encryption has shifted from a research topic to a procurement mandate, and one Canadian company is trying to turn that regulatory wave into regional footholds. Its ...